Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NS3O
|
|||
| Drug Name |
TT10
|
|||
| Synonyms |
EBVST; GVYPHJQPOHDZEI-UHFFFAOYSA-N; TT-10; 2230640-94-3
Click to Show/Hide
|
|||
| Indication | Nasopharyngeal carcinoma [ICD-11: 2B6B] | Phase 3 | [1] | |
| Company |
Tessa Therapeutics Singapore
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H10FN3OS2
|
|||
| Canonical SMILES |
C=CCNC1=NC(=C(S1)C(=O)C2=CC=C(S2)F)N
|
|||
| InChI |
1S/C11H10FN3OS2/c1-2-5-14-11-15-10(13)9(18-11)8(16)6-3-4-7(12)17-6/h2-4H,1,5,13H2,(H,14,15)
|
|||
| InChIKey |
GVYPHJQPOHDZEI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.